Novel Evidence on Hepatitis B Virus Infection in Dialysis

Lok A.S.F. Hepatitis B infection: pathogenesis and management. J Hepatol 2000; 32(suppl. 1): 89–97.

Mioli V.A. , Balestra E. , Bibiano L. Epidemiology of viral hepatitis in dialysis centers: A national survey. Nephron 1992; 61: 278–83.

Petrosillo N. , Puro V. , Ippolito G. and the Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-borne Infections in Dialysis. Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients. Nephron 1993; 64: 636–9.

Albertoni F. , Battilomo A. , Di Nardo V. and The Latium Hepatitis Prevention Group. Nephron 1991; 58: 180–3.

Limido A. , Conte F. , Malberti F. , Spotti D. , Marcelli D. , Locatelli F. Misure di profilassi delle infezioni da virus B e C in Lombardia: Dati del Registro Lombardo Dialisi e Trapianto (RLDT)(Abstract). Giorn lt Nefrol 2000; 17: 266.

Tokars J.L. , Miller E.R. , Alter M.J. , Arduino M.J. National surveillance of dialysis associated diseases in the United States, 1995. ASAIO J 1998; 44: 98–107.

Oguchi H. , Miyasaka M. , Tokunaga S. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol 1992; 38: 36–43.

Jankovic N. , Cala S. , Nadinic B. , Varlai-Knobloch V. , Pavlovic D. Hepatitis C and hepatitis B virus infection in hemodialysis patients and staff: a two year follow-up. Int J Artif Organs 1994; 17: 137–40.

Covic A. , lancu L. , Apetrei C. , Scripcaru D. , Volovat C. , Mititiuc I. , Covic M. Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 1999; 14: 40–5.

Hung K.Y. , Chen W.Y. , Yang C.S. , Lee S.H. , Wu D.J. Hepatitis B and C in hemodialysis patients. Dial Transplant 1995; 24: 135–9.

Guanyu W. , Nan C. , Jiaqi Q. , Shanyan L. , Qinjun X. , Dechang D. Nephrology, dialysis and transplantation in Shangai, 1999. Nephrol Dial Transplant 2000; 15: 961–3.

Cendoroglo Neto M. , Rodrigues Manzano S.I. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Int J Artif Organs 1995; 19: 251–5.

Vladutiu D. , Cosa A. , Neamtu A. lnfection with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map? J Viral Hepat 2000; 7: 313–9.

Marcelli D. , Stannard D. , Conte F. , Held P.J. , Locatelli F. , Port F.K. ESRD patient mortality with adjustment for comorbid conditions in Lombardy (ltaly) versus the United States. Kidney Int 1996; 50: 1013–8.

Josselson J. , Kyser B.A. , Weir M.R. , Sadler J.H. Hepatitis B surface antigenemia in a chronic hemodialysis program: lack of influence on morbidity and mortality. Am J kidney Dis 1987; 6: 456–61.

Jha R. , Kher V. , Naik S. , Elhence R. , Gupta A. , Sharma R.K. Hepatitis B associated liver disease in dialysis patients: role of vaccination. J Nephrol 1993; 6: 98–103.

Maisonneuve P. , Agodoa L. , Gellert R. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93–9.

Szmuness W. , Prince A.M. , Grady G.F. Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. JAMA 1974; 227: 901–6.

Mathurin P. , Mouquet C. , Poynard T. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 257–63.

Friedman E.A. , Thomson G.E. Hepatitis complicating chronic hemodialysis. Lancet 1966; 2: 675–8.

Garibaldi R.A. , Forrest J.N. , Bryan J.A. , Hanson B.F. , Dismukes W.E. Hemodialysis-associated hepatitis. JAMA 1973; 225: 384–9.

Parsons F.M. , Brunner F.P. , Gurland H.J. , Harlen H. Combined report of regular dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc 1971; 8: 3–27.

Snydman D. , Bryan J. , Hanson B. Hemodialysis-associated hepatitis in the United States- 1972. J Infect Dis 1975; 132: 109–13.

CDC. Control measures for hepatitis type B in dialysis centers. Viral Hepatitis lnvestigations and Control Series, November 1977.

Alter M.J. , Favero M.S. , Maynard J.E. Impact of infection control strategies on the incidence of dialysis associated hepatitis in the United States. J Infect Dis 1986; 153: 1149–51.

Degos F. , Lugassy C. , Degott C. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. Gastroenterology 1988; 94: 151–6.

Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other blood-borne pathogens in healthcare settings. MMWR 1988; 37: 377–82.

CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47: 1–39.

Teles S.A. , Martins R.M.B. , Vanderborght B. , Stuyver L. , Gaspar A.M.C. , Yoshida C.F.T. Hepatitis B virus: genotypes and subtypes in Brazilian hemodialysis patients. Artif Organs 1999; 23: 1074–8.

Centers for Disease Control and Prevention. Outbreaks of hepatitis B virus infection among hemodialysis patients-California, Nebraska, and Texas, 1994. JAMA 1996; 275: 1394–5.

Hutin Y.J.F. , Goldstein S.T. , Varma J.K. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Infect Control Hosp Epidemiol 1999; 20: 731–5.

Fukuda K. CDC unpublished data, 1993.

Kellerman 5, Alter M.J. Preventing hepatitis B and hepatitis C virus infection in endstage renal disease patients: back to basics. Hepatology 1999; 29: 291–3.

Tanaka S. , Yoshiba M. , lino S. A common-source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutants. Kidney Int 1995; 48: 1972–8.

Cendoroglo Neto M. , Draibe S.A. , Silva A.E.B. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995; 10: 240–6.

Ursea N. , Patrichi D. , Rus E. , Verzan C. , Andronescu D. lncident a markerului virusului hepatitei C şi corelatiile sale cu alti parametri la bolnavii hemodializati cronic in perioada 1991–1995 in centrul de hemodializ al Spitalului Clinic de Nefrologie ‘Dr Carol Davilla’ Bucuresti. Al ll-lea Congres National de Nefrologie si Dializa (Vol. Rez.), lasi, 1995: 116.

Vladutiu D. , Neamtu A. , Farcas A. , State D. , Braila M. Infectiile cu virusurile hepatitice S si C la bolnavii cu insuficienta renala cronica tratati cui hemodializa. Clujul Med 1996; 4: 487–91.

Simmonds P. , Smith D.B. , McOmish F. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS5 regions. J Gen Virol 1994; 75: 1053–61.

Salminen M. , Nykaen A. , Brummer-Korvenkontio H. , Kantanen M.L. , Liitsola K. , Leiniikki P. Molecular epidemiology of HIV-l based on phylogenetic analysis of in vivo gag p7/p9 direct sequences. Virology 1993; 195: 185–94.

Okamoto H. , Tsuda F. , Sakugawa H. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes. J Gen Virol 1988; 69: 2575–83.

Norder H. , Hammas B. , Lofdahl S. , Couroucè A.M. , Magnius L.O. Comparison of the aminoacid sequence of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 1992; 73: 1201–8.

Norder H. , Hammas B. , Lee S.D. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 1993; 74: 1341–18.

Arauz-Ruiz P. , Norder H. , Visona K.A. , Magnius L.O. Genotype F prevails in HBV infected patients of hispanic origin in Central America and may carry to precore stop mutant. J Med Virol 1997; 51: 305–12.

Couroucè A.M. , Holland P. , Muller P.V. , Soulier J.P. HBs antigen subtypes: proceedings of the International Worshop of HBs antigen subtypes. Bibl Haematol 1976; 42: 1–158.

Couroucé-Pauty A.M. , Plancon A. , Soulier J.P. Distribution of HBsAg subtypes in the world. Vox Sang 1983; 44: 197–211.

Zanetti A.R. , Tanzi E. , Romano L. Kinetics of antibody response to hepatitis B virus determinants and to recombinant vaccines in Italy. J Med Virol 1990; 32: 219–24.

Waters J.A. , O'Rourke S.M. , Richardson S.C. , Papevangelou G. , Thomas H.C. Qualitative analysis of the humoral immune response to the a determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine. J Med Virol 1987; 21: 155–60.

Hopp T.P. , Woods K.R. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Ac Sc 1981; 78: 290–6.

Hepatitis Surveillance Report No. 30. Center Disease Control, US Dept of Health, Education and Welfare, Atlanta, 1969; 15–20.

Favero M.S. Guidelines for the care of patients hospitalized with viral hepatitis. Ann Intern Med 1979; 91: 872–5.

Bond W.W. , Favero M.S. , Petersen N.J. , Gravelle C.R. , Ebert J.W. , Maynard J.E. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981; 1: 550–1.

La Force F.M. , Nelson M. Air-rinsing after dialysis. A mode of transmission of hepatitis virus. JAMA 1975; 233: 331–5.

Almeida J.D. , Kulatilake A.E. , Mackay D.H. Possible airborne spread of serum-hepatitis virus within a haemodialysis unit. Lancet 1971; 2: 849–50.

Alter M.J. , Ahtone J. , Maynard J.E. Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit. Ann Intern Med 1983; 99: 330–3.

Carl M. , Francis D.P. , Maynard J.E. A common-source outbreak of hepatitis B in a hemodialysis unit. Dial Transplant 1983, 12: 222–9.

Favero M.S. , Maynard J.E. , Petersen N.J. Hepatitis-B antigen on environmental surfaces. (Letter) Lancet 1973; 2: 1973.

Niu M.T. , Penberthy L.T. , Alter M.J. , Armstrong C.W. , Miller G.B. , Hadler S.C. Hemodialysis-associated hepatitis B: report of an outbreak. Dial Transplant 1989; 18: 542–7.

Favero M.S. , Deane N. , Leger R.T. , Sosin A.E. Effect of multiple use of dialyzers on hepatitis B incidence in patients and staff. JAMA 1981; 245: 166–7.

Alter M.J. , Favero M.S. , Miller J.K. , Coleman P.J. , Bland L.A. Reuse of hemodialyzers. Results of nationwide surveillance for adverse effects. JAMA 1988; 260: 2073–6.

Andrew W. , Harihan S. , Saha V. , John J.T. , Kirubakaran M.G. , Shastry J.G.M. Biochemical evaluation of ultrafiltrate in dialysis-dependent HBsAg-positive patients. (Letter) Nephron 1988 49: 88.

Moynot A. , Lazizi Y. , Dubreuil P. , Buisson C. , Pillot J. Nature of HBsAg ultrafiltrate of haemodialysed patients: Presence of viral DNA (Letter). Nephrol Dial Transplant 1992; 7: 732.

Kroes A.C.M. , Van Bommel E.F.H. , Niesters H.G.M. , Weimar W. Hepatitis B viral DNA detectable in dialysate (Letter). Nephron 1994; 67: 369.

De Jong G.M.T. , De Bruin W. , Verresen L. , Moshage H. , Desmyter J. , Yap S.H. High-flux membranes are not permeable to hepatitis B virus DNA (Letter). Nephron 1992; 60: 368.

Butterworth L.A. , Prior S.L. , Buda P.J. , Faoagali J.L. , Cooksley W.G.E. Comparison of four methods for quantitative measurement of hepatitis B viral DNA. J Hepatol 1996; 24: 686–91.

Chisari F.V. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Topics Microbiol Immunol 1996; 206: 149–71.

Bond W.W. , Favero M.S. , Petersen N.J. , Ebert J.W. Inactivation of hepatitis B virus by intermediate to high level disinfectant chemicals. J Clin Microbiol 1983; 18: 535–8.

Clementi M. , Riccola S. The effect of the disinfectant AMU2SO vs. hepatitis B virus analyzed using MADT (Morphological alteration and disintegration test). Acta Toxicologica et Therapeutica 1999; XX: 37–42.

Degremont A. , Vaillant P. , Collet M. , Man N.K. Eradication of biofilm by a procedure including cleaning and autoclavage (Abstract). Am J Nephrol 1998; 9: 170.

Barnì G. , Bartolomé J. , Traver J.A. , Cabrerizo M. , Selgas R. , Carreno V. Autoclaving eliminates hepatitis C virus from a hemodialysis monitor contaminated artificially. J Med Virol 2000; 60: 139–43.